作者: Chuan-ling Qiao , Kang-zhen Yu , Yong-ping Jiang , Yong-qing Jia , Guo-bin Tian
DOI: 10.1080/0307945021000070688
关键词: Virus 、 Nucleoprotein 、 Recombinant virus 、 Virology 、 Fowlpox virus 、 Biology 、 Microbiology 、 Vaccination 、 Neuraminidase 、 Influenza A virus 、 Influenza A virus subtype H5N1
摘要: Inactivated whole avian influenza virus (AIV) vaccine provides protection against homologous haemagglutinin (HA) subtype virus, but poor a heterologous HA virus. Moreover, it induces chickens to produce antibodies cross-reactive antigens, especially nucleoprotein, which is limits AIV serological surveillance. In this study, recombinant fowlpox co-expressing (H5 subtype) and NA (NI subtype)genes of was evaluated for its ability protect intramuscular challenge with lethal dose highly pathogenic (HP) AIV. Susceptible were also vaccinated by wing-web puncture the parent Following 4 weeks later HPAIV, all protected, while either unaltered or unvaccinated controls experienced 100% mortality following challenge. This accompanied high levels specific antibody respective components vaccine. The above results showed that rFPV-HA-NA could be potential replace current inactivated vaccines preventing AI.